SEC Filing Analysis: QUAKER CHEMICAL CORP (KWR)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Senior Vice President and Chief Technology Officer, Christine Procopio Johnson, was granted 913 Restricted Stock Units (RSUs) as part of a standard executive compensation plan.
• Market Impact: The transaction is expected to have a neutral and negligible impact on the stock, as it is a routine, non-cash award with minimal dilutive effect.

Company Information

Field	Value
Company	QUAKER CHEMICAL CORP
Ticker Symbol	KWR
CIK	0000081362
Industry	Miscellaneous Products of Petroleum & Coal

Insider Information

Field	Value
Name	Johnson Christine Procopio
CIK	0002087537
Title/Position	SVP, CTO
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-15
Transaction Code	A (Grant)
Security Type	Restricted Stock Units
Shares Involved	913
Price Per Share	$0.00
Total Value	$0
Shares Owned After	913
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	913
% of Shares Outstanding	0.005%
Post-Transaction Ownership	913 shares (0.005% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a $2.30 billion market capitalization, this grant is immaterial in value and scope.
• Ownership Concentration: The insider's resulting ownership of 913 shares represents a very small fraction (0.005%) of the total shares outstanding, indicating this grant does not significantly alter ownership concentration.
• Dilution Impact: The potential dilution from these 913 shares is negligible at 0.005% of the 17.4 million shares outstanding. This is a common and expected level of dilution from executive compensation plans.
• Transaction Significance: The transaction's significance is low. It is a non-open market transaction with zero cash value at the time of grant, representing a standard form of equity compensation rather than an insider's market sentiment.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Equity grants are a routine part of executive compensation and do not signal new information about the company's performance or outlook. The market typically anticipates such grants.

Volume & Sentiment

• Expected Volume Impact: None. The grant is not an open-market transaction and will not affect trading volume.
• Sentiment Indicator: Neutral. This filing is informational and does not carry a bullish or bearish signal.

Investment Insights

Positive Market Indicators

• The grant aligns the CTO's long-term interests with those of shareholders, as the value of the RSUs is tied to the company's future stock performance.

Risk Factors

• No immediate risk factors are indicated by this filing. It is a standard corporate governance procedure.

Key Takeaways

1. Routine Compensation: This is a standard equity award for a senior executive.
2. Minimal Dilution: The impact on existing shareholders is negligible, with potential dilution at only 0.005%.
3. No Market Signal: The transaction does not reflect an insider's investment decision or sentiment regarding the stock's current valuation.

Additional Context

Transaction Notes

• Vesting Schedule: The filing's footnotes indicate the RSUs vest in three annual installments beginning on March 15, 2026, which encourages long-term retention and performance.
• Special Circumstances: These are time-based restricted stock units granted under the company's Long-Term Performance Incentive Plan.